Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Inhibition of platelet thromboxane synthetase by sulfasalazine
William F. Stenson
, Elizabeth Lobos
Division of Gastroenterology
Institute of Clinical and Translational Sciences
DBBS - Molecular Cell Biology
Siteman Cancer Center
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of platelet thromboxane synthetase by sulfasalazine'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Thromboxane-A Synthase
92%
Sulfasalazine
78%
Blood Platelets
47%
Inhibitory Concentration 50
21%
Prostaglandin-Endoperoxide Synthases
19%
Mesalamine
15%
Lipoxygenase
15%
Sulfapyridine
9%
5-hydroxy-6,8,11,14-eicosatetraenoic acid
9%
Neutrophils
9%
Anti-Inflammatory Agents
8%
Arachidonate 5-Lipoxygenase
8%
Leukotriene B4
7%
Arachidonic Acid
6%
Ulcerative Colitis
5%
Colon
4%
Lipids
3%
Pharmaceutical Preparations
2%
Therapeutics
1%
Chemical Compounds
Sulfasalazine
100%
Thromboxane
85%
Antiinflammatory
11%
Sulfapyridine
9%
Leukotriene B4
8%
Cleavage
8%
Chemotactic
8%
Arachidonic Acid
6%
Pharmacological Metabolism
4%
Lipid
4%
Block Like Crystal
4%
Drug
3%
Acid
2%